A word from
our CEO,

The landscape at PUF Ventures is experiencing a major change to our future direction. Over the next several weeks, we will be unveiling a new name, brand and website as we create the fertile ground from which PUF will grow for the many years to come.

Today’s exciting announcement regarding Health Canada’s granting AAA Heidelberg a medical cannabis cultivation license demonstrates our commitment to becoming a leading company in the emerging cannabis marketplace in Canada and around the world. While it has been a challenge navigating the changing regulatory environment as we pursued our license to produce medical cannabis, our patience has paid off and we are now in the position to quickly move the Company forward to the benefit of PUF shareholders.

Over the past 18 months we have focused our strategy to diversify and mitigate risk in response to the ever-changing cannabis sector. With the legalization of cannabis in Canada occurring on October 17, 2018, we are witnessing the birth of an entire new industry. Pioneers and early adopters like PUF will not only become the leaders of this new multi-billion-dollar industry, but they will also establish how the industry will work for future generations. We are now officially part of that conversation.

We have laid out a roadmap which allows PUF to succeed in the current and future landscape of the global cannabis industry; we have taken steps to expand our operations on a domestic and international basis; we have created ancillary businesses which provides our Company value today and in the future. Much work has been done and there is much more work to do.

Our new brand will better reflect the diversified nature of our business and the multiple holdings that make PUF great. More news to come.

Below you will find links to the dynamic collection of PUF related companies.


Derek Ivany
President & CEO

Our Portfolio Holdings
Industry Partners
News Room

VANCOUVER, Nov. 16, 2017 /CNW/ – PUF Ventures Inc. (“PUF” or the “Company”) (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license applicant, is pleased to announce that PUF Ventures Australia (“PUFA”) has retained Mr. Casey Houwelings and Mr. Peter Cummings as greenhouse consultants for the medical cannabis Northern River Project, a 1,200,000-square foot greenhouse being constructed in north eastern New South Wales. Houwelings and Cummings will contribute to the design and construction of the most technically advanced and environmentally sustainable greenhouse to grow medical cannabis.

Stay Informed!
We will send you information on our brands development,
news about the industry and investment oportunities.